logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabFulminant type-1 diabetes mellitus and hypophysitis: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1894卷 / 1期
关键词:
D O I:
10.1007/s40278-022-10305-7
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:192 / 192
相关论文
共 50 条
  • [1] NivolumabFulminant type-1 diabetes mellitus and hypophysitis: case report
    Reactions Weekly, 2018, 1698 (1) : 260 - 260
  • [2] Ipilimumab/nivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2022, 1904 (1) : 266 - 266
  • [3] Ipilimumab/nivolumabFulminant type 1 diabetes: case report
    Reactions Weekly, 2017, 1656 (1) : 280 - 280
  • [4] Ipilimumab/nivolumabThyroiditis, hypophysitis and fulminant type-1 diabetes mellitus
    Reactions Weekly, 2024, 2007 (1) : 196 - 196
  • [5] Interferon-beta/ipilimumab/nivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2018, 1715 (1) : 140 - 140
  • [6] NivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2019, 1782 (1) : 247 - 247
  • [7] NivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2023, 1957 (1) : 422 - 422
  • [8] NivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2017, 1663 (1) : 227 - 227
  • [9] NivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2016, 1631 (1) : 140 - 140
  • [10] NivolumabFulminant type 1 diabetes mellitus: case report
    Reactions Weekly, 2018, 1721 (1) : 213 - 213
← 12345 →